(INNS)
TEROPAVIMAB(INND)
TEROPAVIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120 ENVELOPE GLYCOPROTEIN (HIV-1 GP120) CD4 BINDING SITE (CD4BS)], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-452) [VH (HOMO SAPIENS IGHV1- 2*02, INSERT D84.1, F84.2, D85.2, T85.1 (77-80), (62.7%) - (IGHD) -IGHJ3*01 (85.7%) Q120>S (115), M123>Q (118), CDR-IMGT [8.8.12] (26-33.51-58.101-112)) (1-123) -HOMO SAPIENS IGHG1*01 G1M17,1, G1V24 CH3 L107, S114 (CH1 K120 (220) (124-221), HINGE 1-15 (222-236), CH2 (237-346), CH3 D12 (362), L14 (364), M107>L (434), N114>S (440) (347-451), CHS K2>DEL (452)) (124-452)], (226-206')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-206') [VKAPPA (HOMO SAPIENS IGKV1-33*01 (72.8%) -IGKJ5*01 (71.4%) E119>D (97), I120>L (98), CDR-IMGT [3.3.13] (26-28.46-48.85-97)) (1'-99') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (145), V101 (183) (100'-206')]; DIMER (232-232'':235-235'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1SV CELL LINE, GLYCOFORM ALFA(WHO)
TEROPAVIMABUM(INN)